NCT05866354 2023-11-27To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid MalignanciesZai Lab (Hong Kong), Ltd.Phase 1 Completed19 enrolled